Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 1.00 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.77 |
| ▸ | TP53 | P04637 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.77 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.75 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17418374 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL331847 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5304363 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL1010481 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL640740 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL923926 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL332106 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL332945 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5300928 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 | |
| SCHEMBL5287730 | 1.00 | DNM1 (1.00) | DNM1SLC22A1ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2848336-B1 | METHOD FOR MANUFACTURING HOLLOW METAL NANOPARTICLES | LG CHEMICAL LTD (KR) | 2017-04-26 | — | — | EP | claimed |
| EP-2746348-B1 | Cellulosic and cellulose ether solutions and their use | SE TYLOSE GMBH & CO KG (DE) | 2015-10-21 | — | — | EP | claimed |
| EP-1809279-B1 | PARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR | BAXTER INT (US) | 2013-05-29 | — | — | EP | claimed |
| EP-1686962-B9 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2012-10-03 | — | — | EP | claimed |
| EP-1871345-B1 | NANOPARTICULATE ERLOTINIB FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2012-08-01 | — | — | EP | claimed |
| EP-1585502-B9 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2012-05-09 | — | — | EP | claimed |
| EP-1553927-B9 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2011-09-21 | — | — | EP | claimed |
| EP-1585502-B1 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2011-06-29 | — | — | EP | claimed |
| EP-1686962-B1 | NANOPARTICULATE COMPOSITIONS HAVING A PEPTIDE AS A SURFACE STABILIZER | ELAN PHARMA INT LTD (IE) | 2011-05-18 | — | — | EP | claimed |
| EP-1553927-B1 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2010-11-10 | — | — | EP | claimed |
| EP-1429731-B1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2007-01-03 | — | — | EP | claimed |
| EP-1490030-B1 | NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS | ELAN PHARMA INT LTD (IE) | 2006-10-25 | — | — | EP | claimed |
| US-20060049107-A1 | Surfactant-like polymer gel and a method for separating material using same | THE PROVINCE OF GYEONGGI (KR) | 2006-03-09 | — | — | US | claimed |
| EP-1553927-A2 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | Elan Pharma International Limited (IE) | 2005-07-20 | — | — | EP | claimed |
| WO-2005000265-A2 | GEL-STABILIZED NANOPARTICULATE ACTIVE AGENT COMPOSITIONS | ELAN PHARMA INTERNATIONAL LTD. (IE) | 2005-01-06 | — | — | WO | claimed |
| WO-2004013208-A1 | A SURFACTANT-LIKE POLYMER GEL AND A METHOD FOR SEPARATING MATERIAL USING SAME | KIM HONGDOO (KR) | 2004-02-12 | — | — | WO | claimed |
| EP-0408017-B1 | DELIVERY SYSTEMS FOR QUATERNARY AND RELATED COMPOUNDS | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| EP-0272674-B1 | PROCESS FOR PRODUCING 2,6-DICHLOROBENZYL ALCOHOL | HODOGAYA CHEMICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | claimed |
| EP-0408017-A2 | Delivery systems for quaternary and related compounds | UNION CARBIDE CHEMICALS AND PLASTICS COMPANY, INC. (US) | 1991-01-16 | — | — | EP | claimed |
| US-4229356-A | Production of vitamin K1 and vitamin K2 | WAKUNAGA YAKUHIN KABUSHIKI KAISHA (JP) | 1980-10-21 | — | — | US | claimed |